Dexamethasone sodium phosphate SR by Taiwan Liposome for Osteoarthritis Pain: Likelihood of Approval

Dexamethasone sodium phosphate SR is under clinical development by Taiwan Liposome and currently in Phase III for Osteoarthritis Pain.

Artificial heart maker’s cash runway shrinks to 1 month after supply woes hurt sales

Dive Brief: Carmat has warned investors that it has enough money to fund operations only through the end of next month, creating a pressing need

September 28, 2023

Menopause Can Negatively Affect Women’s Careers

PHILADELPHIA — Four in 10 women said that menopause or perimenopause had a negative impact on their work experience and that there’s a stigma about

October 4, 2023

Caffeine vs. creatine: The impact on cognitive and physical performances

The individual and combined effects of caffeine and creatine nitrate on cognitive and exercise performance.

March 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.